These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7654854)

  • 1. Cytokines in the pathophysiology and treatment of chronic B-cell malignancies. A review.
    Schuler M; Huber C; Peschel C
    Ann Hematol; 1995 Aug; 71(2):57-63. PubMed ID: 7654854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
    Brass U; Tretter T; Schneller F; Schuler M; Huber C; Peschel C
    J Interferon Cytokine Res; 1999 Apr; 19(4):335-43. PubMed ID: 10334384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association?
    Giné E; Bosch F; Villamor N; Rozman M; Colomer D; López-Guillermo A; Campo E; Montserrat E
    Leukemia; 2002 Aug; 16(8):1454-9. PubMed ID: 12145685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
    Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
    Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant IFN-alpha in lymphomas.
    Ziegler-Heitbrock HW; Thiel E
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):213S-215S. PubMed ID: 1701808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K signaling pathway in normal B cells and indolent B-cell malignancies.
    Pongas G; Cheson BD
    Semin Oncol; 2016 Dec; 43(6):647-654. PubMed ID: 28061982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia.
    Mainou-Fowler T; Prentice AG
    Leuk Lymphoma; 1996 May; 21(5-6):369-77. PubMed ID: 9172801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine.
    Chow KU; Boehrer S; Geduldig K; Krapohl A; Hoelzer D; Mitrou PS; Weidmann E
    Haematologica; 2001 May; 86(5):485-93. PubMed ID: 11410411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias.
    Csanaky G; Matutes E; Vass JA; Morilla R; Catovsky D
    Leukemia; 1997 Mar; 11(3):408-15. PubMed ID: 9067581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
    Kraut EH
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Chlorodeoxyadenosine: a new nucleoside agent effective in the treatment of lymphoid malignancies.
    Saven A; Piro LD
    Leuk Lymphoma; 1993; 10 Suppl():43-9. PubMed ID: 8097654
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of a fludarabine induction and alpha-interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
    Zinzani PL; Bendandi M; Magagnoli M; Rondelli D; de Vivo A; Benni M; Zamagni E; Cavo M; Tura S
    Eur J Haematol; 1997 Aug; 59(2):82-8. PubMed ID: 9293855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study.
    Cerhan JR; Janney CA; Vachon CM; Habermann TM; Kay NE; Potter JD; Sellers TA; Folsom AR
    Am J Epidemiol; 2002 Sep; 156(6):527-35. PubMed ID: 12226000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phorbol ester induction of plasmacytoid and hairy cell leukemia features in B-type lymphocytic leukemias: the relation to B-cell differentiation and maturation.
    Gazitt Y; Polliack A
    Blood Cells; 1987; 12(2):413-39. PubMed ID: 3497682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report: Development of Diffuse Large B Cell Lymphoma a Long Time After Hairy Cell Leukemia.
    Nagy ZF; Ferenczi K; Istenes I; Eid H; Bödör C; Timár B; Demeter J
    Pathol Oncol Res; 2022; 28():1610338. PubMed ID: 35570843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine.
    Zaja F; Di Loreto C; Amoroso V; Salmaso F; Russo D; Silvestri F; Fanin R; Damiani D; Infanti L; Mariuzzi L; Beltrami CA; Baccarani M
    Leuk Lymphoma; 1998 Feb; 28(5-6):567-72. PubMed ID: 9613987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lymph node stromal cells on the differentiation of a cell line established from an atypical prolymphocytic leukemia with phenotypes of both chronic lymphocytic and hairy cell leukemias.
    Takeuchi H; Amano Y; Katayama I
    Leuk Lymphoma; 1994; 14 Suppl 1():49-56. PubMed ID: 7820053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hairy cell leukemia and allied chronic lymphoid leukemias: current knowledge and new therapeutic options.
    Polliack A
    Leuk Lymphoma; 1997 Dec; 26 Suppl 1():41-51. PubMed ID: 9570679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Chlorodeoxyadenosine treatment in non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia resistant to conventional chemotherapy: results of a multicentric experience. International Society for Chemo-Immunotherapy.
    Brugiatelli M; Holowiecka B; Dmoszynska A; Krieger O; Planinc-Peraica A; Labar B; Callea V; Morabito F; Jaksic B; Holowiecki J; Lutz D
    Ann Hematol; 1996 Aug; 73(2):79-84. PubMed ID: 8774616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Cvetković RS; Perry CM
    Drugs; 2006; 66(6):791-820. PubMed ID: 16706552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.